# Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer

> **NCT00002931** · PHASE2 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 48 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Extragonadal Germ Cell Tumor
- Ovarian Cancer
- Teratoma
- Testicular Germ Cell Tumor

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** carboplatin
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **DRUG:** paclitaxel
- **PROCEDURE:** autologous bone marrow transplantation
- **PROCEDURE:** bone marrow ablation with stem cell support

## Key facts

- **NCT ID:** NCT00002931
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-02
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002931, "Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00002931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*